SCHEMBL938095

SCHEMBL938095

Nc1nc2ccc(-c3cnc(N)c(C(F)(F)F)c3)cn2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 14/20 0.53
PIK3CG P48736 10/20 0.53
PIK3CD O00329 9/20 0.53
PIK3CB P42338 4/20 0.53
PIK3C3 Q8NEB9 1/20 0.53
PI4KB Q9UBF8 1/20 0.53
TNF P01375 1/20 0.46
MTOR P42345 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
CSF1R P07333 1/20 0.41
RET P07949 1/20 0.41
GRK5 P34947 1/20 0.41
MAPK8 P45983 1/20 0.41
CSNK1A1 P48729 1/20 0.41
ACVR1 Q04771 1/20 0.41
PTK2 Q05397 1/20 0.41
TYRO3 Q06418 1/20 0.41
MAP4K2 Q12851 1/20 0.41
DYRK1A Q13627 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL936112 0.78 PIK3CG (0.59) PIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL15743475 0.75 PIK3CA (0.56) PIK3CAPIK3CGPIK3CDPIK3CBPIK3C3
SCHEMBL3095111 0.75 PIK3CD (0.51) PIK3CAPIK3CGPIK3CDPIK3CBMAP4K4
SCHEMBL15743230 0.74 PIK3CA (0.50) PIK3CAPIK3CGPIK3CDPIK3CBPIK3C3
SCHEMBL12909573 0.74 PIK3CD (0.46) PIK3CAPIK3CGPIK3CDPIK3CBDYRK1A
Hydrochloric Acid SCHEMBL936500 0.73 PIK3CD (0.45) PIK3CAPIK3CGPIK3CDPIK3CBDYRK1A
SCHEMBL15743227 0.72 PIK3CA (0.48) PIK3CAPIK3CGPIK3CDPIK3CBPIK3C3
SCHEMBL3664184 0.72 PIK3CG (0.66) PIK3CAPIK3CGPIK3CDPIK3CBMAP4K4
SCHEMBL938152 0.72 PIK3CG (0.74) PIK3CAPIK3CGPIK3CDPIK3CBPAK4
SCHEMBL15743291 0.72 PIK3CD (0.49) PIK3CAPIK3CGPIK3CDPIK3CBPIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222674-B1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LTD (GB) 2015-11-11 EP claimed
US-8865699-B2 Amino triazoles as PI3K inhibitors CELLZOME LTD. (GB) 2014-10-21 US claimed
US-20110021497-A1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LIMITED (GB) 2011-01-27 US claimed
EP-2222674-A1 AMINO TRIAZOLES AS PI3K INHIBITORS Cellzome Limited (GB) 2010-09-01 EP claimed
WO-2009068482-A1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LIMITED (GB) 2009-06-04 WO claimed
EP-2222674-B1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LTD (GB) 2015-11-11 EP disclosed
EP-2222674-B1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LTD (GB) 2015-11-11 EP disclosed
US-8865699-B2 Amino triazoles as PI3K inhibitors CELLZOME LTD. (GB) 2014-10-21 US disclosed
US-8865699-B2 Amino triazoles as PI3K inhibitors CELLZOME LTD. (GB) 2014-10-21 US disclosed
US-8865699-B2 Amino triazoles as PI3K inhibitors CELLZOME LTD. (GB) 2014-10-21 US disclosed
US-20110021497-A1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LIMITED (GB) 2011-01-27 US disclosed
US-20110021497-A1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LIMITED (GB) 2011-01-27 US disclosed
US-20110021497-A1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LIMITED (GB) 2011-01-27 US disclosed
EP-2222674-A1 AMINO TRIAZOLES AS PI3K INHIBITORS Cellzome Limited (GB) 2010-09-01 EP disclosed
WO-2009068482-A1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LIMITED (GB) 2009-06-04 WO disclosed
WO-2009068482-A1 AMINO TRIAZOLES AS PI3K INHIBITORS CELLZOME LIMITED (GB) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021497-A1 AMINO TRIAZOLES AS PI3K INHIBITORS PIK3C3, PIK3R3, PIK3R5 PIK3CA 9/4885PIK3CG 11/4885PIK3CD 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.